Latest news
Loading news…
Protiva Biotherapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Seattle, Washington, United States Founded 2000 1-10 employees For Profit
Protiva Biotherapeutics is a biotechnology company developing nucleic acid based pharmaceutical products.
Protiva Biotherapeutics was acquired by Arbutus Biopharma in 2008 for $23M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
Company Info
- Founded
- 2000
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 1
- HQ
- Seattle, Washington, United States
- Region
- Greater Seattle Area, West Coast, Western US
- Exit date
- Mar 28, 2008
- Closed
- Nov 3, 2018
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -2
- Trend (90d)
- 0
Key People at Protiva Biotherapeutics
CFO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Protiva Biotherapeutics
Loading news…
FAQs about Protiva Biotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.